On September 3, 2026, BTIG started coverage of Tiziana Life Sciences Ltd (TLSA) at Buy.
Among one firm active over the past 90 days, one holds a bullish rating. Four analysts set consensus price targets as of October 30, 2026, with a mean of $8.16, a median of $8.16 and a range of $7.07 to $9.45.
